Summary The UK government is close to reach a £500 million deal with Sanofi and GSK for acquiring millions of doses of COVID- 19 vaccine The Government’s decision to go in for a second vaccine contract seems to be a strategy to dive...
COVID-19 pandemic has affected more than 10.2 million lives including 506,864 deaths reported to the World Health Organization on 01 July 2020, (as of 8:18 AM CEST). As per the information provided by the WHO, a total of 149 vaccines are being tes...
COVID-19 threat still looms with countries struggling to eliminate the novel coronavirus, SARS-CoV-2. While most geographies are grappling with the first wave of virus, the ones who did become COVID-19-free are now facing the second wave. Globally,...
Summary AstraZeneca and Gilead were rumoured to be in potential merger talks The £200 billion speculated merger could have been the biggest ever M&A deal in the sector The pharma industry raises concern over declining inventory level...
Pharma companies making round the clock efforts to find a cure for the Covid-19 Futura Medical Plc despite weak earnings posted humungous gains in May Avacta Group Plc has been successful in generating many Affimer reagents, which help in...
The disruptive Coronavirus chaos has yielded an opportunity for Pharmaceutical & Biotechnology industry and resulting into a blessing in disguise as numerous trials have been launched to come up with the potential vaccine and plausible solutions....
AstraZeneca Plc to replicate UK vaccine deal with other countries amid Covid-19 crisis The world-renowned drugmaker AstraZeneca Plc had sometimes back announced the development and distribution of the novel coronavirus vaccine in partnership with th...
The United Kingdom market headed north with the opening bell (on 11th May 2020, before the market closed), since the investor sentiments are optimistic with the gradual restart of activities. Even the Global markets responded positively as more econo...
The United Kingdom market opened higher today (on 5th May 2020, before the market closed) with a revival in economic activities as several countries easing out the Covid-19 imposed restrictions. Meanwhile, it has been observed that the Pharmaceutical...
Synairgen Plc and E-Therapeutics Plc proving to be the treasure trove A stock priced below £1 a share is often indicative of companies with not so good fundamentals, or one having a shaky near-term outlook. These price range of scrips tend to...
Get a call to receive stock recommendation services from (www.kalkine.co.uk)
